This content is machine translated Interventional valve therapy Gender differences Current evidence on gender differences in interventional valve therapy indicates that the patient pathway of aortic valve stenosis requires awareness regarding symptomatology, diagnosis, prosthesis selection, and life-time management in women.… CME-Test
View Post 7 min This content is machine translated Treatment resistant hypertension Perspectives for CKD patients Chronic kidney disease (CKD) is associated with a number of cardiovascular complications. Because of the high mortality rate attributable to cardiovascular disease, most patients with progressive CKD die before reaching…
View Post 6 min This content is machine translated Light chain amyloidosis New echocardiographic risk score? The prognosis of light chain amyloidosis (AL), a plasma cell dyscrasia, is largely determined by the presence of cardiac involvement. Conventional staging is based on cardiac biomarkers and free light…
View Post 4 min This content is machine translated CV Health Update 2023 Hypercholesterolemia – Strengthen Cardiovascular Prevention At the hybrid event “CV Health Update 2023,” Prof. Isabella Sudano, MD, Senior Physician, Head of Cardiovascular Risk Factors, Department of Cardiology Heart Center University Hospital Zurich, presented the current…
View Post 10 min This content is machine translated Pulmonary arterial hypertension beyond the guideline. IPAH or what else? – IPAH with pulmonary comorbidity Pulmonary hypertension is divided into 5 distinct groups, with group 1 reflecting pulmonary arterial hypertension (PAH). The PH-specific drug therapies approved to date interfere with three different signaling pathways (NO… CME-Test
View Post 4 min This content is machine translated Heart failure (HFpEF) Is cardiac amyloidosis hiding behind it? In those over 65, heart failure is the most common reason for hospitalization. Clarification of the cause of the disease is essential to direct patients to targeted therapy. Patients with…
View Post 5 min This content is machine translated High performance chargers for electric vehicles EMI risk for patients with pacemakers and defibrillators? Battery-powered electric vehicles and their charging stations are a potential source of electromagnetic interference (EMI) for patients with cardiac implantable electronic devices (CIEDs). The new “high power” charging stations have…
View Post 7 min This content is machine translated SCORE2 diabetes 10-year estimate of cardiovascular risk in type 2 diabetes. To develop and validate a recalibrated prediction model (SCORE2-Diabetes) to estimate the 10-year risk of cardiovascular disease in individuals aged over 40 years with type 2 diabetes in four different…
View Post 8 min This content is machine translated Catheter ablation Premature ventricular complexes in the intramural outflow tract Ablation of ventricular outflow tract arrhythmias may be limited by the deep intramural location of the arrhythmogenic source. Therefore, a recent study evaluated the acute and long-term outcomes of patients…
View Post 7 min This content is machine translated CLEAR Outcomes Study New results on bempedoic acid Statin-intolerant patients represent a difficult patient group to treat in lipid management. Now, with the CLEAR Outcomes study, it has been shown that a therapeutic option with a beneficial effect…
View Post 5 min This content is machine translated Heart failure in type 2 diabetes Success story of SGLT-2 inhibitors – impressive evidence base. The SGLT(“sodium glucose-linked transporter”)-2 inhibitors have demonstrated cardioprotective effects in addition to antidiabetic effects. The current evidence supports the benefit of several agents of SGLT-2-i in the treatment of heart…
